ClinicalTrials.gg
CompletedNCT05717296VASCUORGUpdated May 1, 2026

Evaluation of the Effectiveness of a Multimedia Information Site in Reducing Preoperative Anxiety in Vascular Surgery Patients.

An interventional study of anxiety survey and scale of satisfaction in Vascular Diseases, sponsored by Centre Chirurgical Marie Lannelongue. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by Centre Chirurgical Marie Lannelongue · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Anxiety is a phenomenon that frequently occurs before surgery. Preoperative anxiety has been studied in several disciplines, including rheumatology, anesthesia, stomatology and cardiology. The implications of preoperative anxiety in terms of morbidity and mortality have also been studied and are well known: intraoperative hemodynamic disorders, increased postoperative mortality, increased consumption of anesthetic agents.

Several scales have been developed to quantify preoperative anxiety, the most frequently used being the visual analog scale and the Amsterdam scale. Several approaches have been considered to reduce preoperative anxiety, such as hypnosis, music, or multimedia.

However, no consensus tool has been developed for vascular surgery patients. Similarly, no study has examined preoperative anxiety in this specific population.

The aim of this study is to evaluate a new multimedia information medium for vascular surgery patients and to assess its effectiveness in reducing preoperative anxiety.

02

Conditions studied

  • Vascular Diseases

Browse trials for

03

In context

Vascular Diseases

694 studies on the registry are indexed under Vascular Diseases; 128 are open to participants now.

This study's enrollment of 250 is above the median of 96 across 419 interventional studies indexed under Vascular Diseases.

Browse Vascular Diseases studies →

Lead sponsor

Centre Chirurgical Marie Lannelongue is the lead sponsor of 40 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient over 18 years of age
  • Patient affiliated to a health insurance plan
  • French-speaking patient
  • Patient who has given free, informed and express consent
  • Patient who has consulted a vascular surgeon for a scheduled procedure
  • Patient with internet and telephone access to view videos
  • Patient referred for surgical or endovascular treatment for obliterative arteriopathy of the lower limbs, abdominal aortic aneurysm and surgical treatment for carotid stenosis

Exclusion criteria

Exclusion Criteria:

  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under court protection
  • Patients with blindness
  • Patients with severe cognitive impairment
  • Patients without access to a digital support to view the videos
  • Pregnant and breastfeeding women
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (actual)

Study arms

  • Experimental
    with multimedia support

    Other: anxiety survey · Other: scale of satisfaction · Other: Multimedia Information

  • Sham comparator
    without multimedia support

    Other: anxiety survey

Interventions

  • Otheranxiety survey

    surgery and anesthesia anxiety questionnaire

  • Otherscale of satisfaction

    scale of satisfaction of multimedia

  • OtherMultimedia Information

    Patients randomized to the "with multimedia support arm "will have access to educational videos focused on the vascular surgery they are to receive.

06

What researchers measure

Primary outcomes

  1. Evaluation of the evolution of preoperative anxiety in patients with access to multimedia with the help of a numerical scale compared to the group of patients without multimedia support

    The patient rates his anxiety between 0 and 10: 0 no anxiety; 10 maximum anxiety

    Time frame: Day 0 ; Day 1 ; Day before the surgery

Secondary outcomes

  1. Assessment of satisfaction with the multimedia support using a 4-point scale: 1) Very satisfied ; 2) Satisfied ; 3) Not very satisfied ; 4) Not satisfied

    Time frame: Day before the surgery

07

Study locations

1 site
  • Groupe hospitalier Paris Saint Joseph-hopital Marie Lannelongue
    Le Plessis-Robinson, Île-de-France Region 92350, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05717296
Lead sponsor
Centre Chirurgical Marie Lannelongue
Responsible party
Sponsor
First posted
Feb 8, 2023
Start date
Jun 29, 2022
Primary completion
Jun 29, 2023
Completion
Dec 31, 2025
Last update
May 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion